debio-1347 has been researched along with Glioma* in 1 studies
1 other study(ies) available for debio-1347 and Glioma
| Article | Year |
|---|---|
Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas.
Topics: Adolescent; Benzimidazoles; Brain Neoplasms; Child; Child, Preschool; Glioma; Humans; Infant; Pyrazoles; Receptors, Fibroblast Growth Factor | 2021 |